Agenus issues initial coin offering to fund immuno-oncology drug’s development

Agenus issues initial coin offering to fund immuno-oncology drug’s development

The drugmaker called its offering, scheduled for next month and meant to finance development of the drug AGEN2034, a first in healthcare and said it expects others to use the same means to raise capital.

Source: http://bit.ly/2RXtjqE